TTo investigate the diagnostic performance of early acquisition compared to late imaging for the detection of local recurrence of prostate cancer by means of 18F-FCH PET/CT. Materials and methods 99 patients with radical prostatectomy (mean PSA 3.9 ± 5.03) were subjected to early dynamic PET/CT acquisition of the pelvis and a whole body PET/CT in the same exam session. None of the patients examined was subjected to radiotherapy for local or distant recurrence. All the subjects were taken off hormonal therapy. Results 58 subjects did not show local recurrence in both early and late acquisition, 22 were positive in both modalities, 10 showed a positive early and a negative late acquisition while 9 showed a negative early and a positive la...
We evaluated the potential of 18F-fluoromethyldimethyl-2-hydroxyethyl-ammonium (FCH) PET/CT in the d...
Early detection of recurrence is clinically important and can im-prove the prognosis and survival of...
Purpose: Prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in patients with bioc...
TTo investigate the diagnostic performance of early acquisition compared to late imaging for the det...
PURPOSE: To highlight a new imaging acquisition protocol during 18F-fluorocholine PET/CT in patients...
We sought to determine predictive factors (patient and prostate-specific antigen [PSA] characteristi...
AIM: Contribution of 3-phase 18F-fluorocholine PET/CT in suspected prostate cancer recurrence at ear...
Purpose: To determine when 18F-choline PET/CT can truly identify local recurrence of prostate cancer...
9Purpose: We evaluated the potential of PET/CT and [F-18] fluoromethylcholine (FCH) in the assessmen...
International audiencePurposeTo compare the diagnostic performance of 18F-Fluorocholine PET/CT (FCH-...
The main objective of this prospective study was to determine the impact of multiphasic acquisition ...
In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA) level is a f...
Objectives: We evaluated the potential role of (18)FFMC PET/CT (PET) in the detection of recurrent ...
To prospectively evaluate the clinical impact and the diagnostic performance of FCH-PET/CT in patien...
To evaluate the diagnostic performance of a whole-body 18F-choline (FCH) hybrid PET/MRI for prostate...
We evaluated the potential of 18F-fluoromethyldimethyl-2-hydroxyethyl-ammonium (FCH) PET/CT in the d...
Early detection of recurrence is clinically important and can im-prove the prognosis and survival of...
Purpose: Prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in patients with bioc...
TTo investigate the diagnostic performance of early acquisition compared to late imaging for the det...
PURPOSE: To highlight a new imaging acquisition protocol during 18F-fluorocholine PET/CT in patients...
We sought to determine predictive factors (patient and prostate-specific antigen [PSA] characteristi...
AIM: Contribution of 3-phase 18F-fluorocholine PET/CT in suspected prostate cancer recurrence at ear...
Purpose: To determine when 18F-choline PET/CT can truly identify local recurrence of prostate cancer...
9Purpose: We evaluated the potential of PET/CT and [F-18] fluoromethylcholine (FCH) in the assessmen...
International audiencePurposeTo compare the diagnostic performance of 18F-Fluorocholine PET/CT (FCH-...
The main objective of this prospective study was to determine the impact of multiphasic acquisition ...
In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA) level is a f...
Objectives: We evaluated the potential role of (18)FFMC PET/CT (PET) in the detection of recurrent ...
To prospectively evaluate the clinical impact and the diagnostic performance of FCH-PET/CT in patien...
To evaluate the diagnostic performance of a whole-body 18F-choline (FCH) hybrid PET/MRI for prostate...
We evaluated the potential of 18F-fluoromethyldimethyl-2-hydroxyethyl-ammonium (FCH) PET/CT in the d...
Early detection of recurrence is clinically important and can im-prove the prognosis and survival of...
Purpose: Prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in patients with bioc...